|
| |
| | | 58007 | | 24.07.2007 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tasigna 200 mg | Kapseln | Capsules (Nilotinibum 200 mg) | L01EA03 | CI | | 02 | Tasigna 150 mg | Kapseln | Capsules (Nilotinibum 150 mg) | L01EA03 | CI | | 03 | Tasigna 50 mg | Kapseln | Capsules (Nilotinibum 50 mg) | L01EA03 | |
|
|
|
